CO6_HUMAN - dbPTM
CO6_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID CO6_HUMAN
UniProt AC P13671
Protein Name Complement component C6
Gene Name C6
Organism Homo sapiens (Human).
Sequence Length 934
Subcellular Localization Secreted.
Protein Description Constituent of the membrane attack complex (MAC) that plays a key role in the innate and adaptive immune response by forming pores in the plasma membrane of target cells..
Protein Sequence MARRSVLYFILLNALINKGQACFCDHYAWTQWTSCSKTCNSGTQSRHRQIVVDKYYQENFCEQICSKQETRECNWQRCPINCLLGDFGPWSDCDPCIEKQSKVRSVLRPSQFGGQPCTAPLVAFQPCIPSKLCKIEEADCKNKFRCDSGRCIARKLECNGENDCGDNSDERDCGRTKAVCTRKYNPIPSVQLMGNGFHFLAGEPRGEVLDNSFTGGICKTVKSSRTSNPYRVPANLENVGFEVQTAEDDLKTDFYKDLTSLGHNENQQGSFSSQGGSSFSVPIFYSSKRSENINHNSAFKQAIQASHKKDSSFIRIHKVMKVLNFTTKAKDLHLSDVFLKALNHLPLEYNSALYSRIFDDFGTHYFTSGSLGGVYDLLYQFSSEELKNSGLTEEEAKHCVRIETKKRVLFAKKTKVEHRCTTNKLSEKHEGSFIQGAEKSISLIRGGRSEYGAALAWEKGSSGLEEKTFSEWLESVKENPAVIDFELAPIVDLVRNIPCAVTKRNNLRKALQEYAAKFDPCQCAPCPNNGRPTLSGTECLCVCQSGTYGENCEKQSPDYKSNAVDGQWGCWSSWSTCDATYKRSRTRECNNPAPQRGGKRCEGEKRQEEDCTFSIMENNGQPCINDDEEMKEVDLPEIEADSGCPQPVPPENGFIRNEKQLYLVGEDVEISCLTGFETVGYQYFRCLPDGTWRQGDVECQRTECIKPVVQEVLTITPFQRLYRIGESIELTCPKGFVVAGPSRYTCQGNSWTPPISNSLTCEKDTLTKLKGHCQLGQKQSGSECICMSPEEDCSHHSEDLCVFDTDSNDYFTSPACKFLAEKCLNNQQLHFLHIGSCQDGRQLEWGLERTRLSSNSTKKESCGYDTCYDWEKCSASTSKCVCLLPPQCFKGGNQLYCVKMGSSTSEKTLNICEVGTIRCANRKMEILHPGKCLA
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
29C-linked_GlycosylationCFCDHYAWTQWTSCS
CCCCCCEEECCEECC
5.0710551839
29C-linked_GlycosylationCFCDHYAWTQWTSCS
CCCCCCEEECCEECC
5.0710551839
32C-linked_GlycosylationDHYAWTQWTSCSKTC
CCCEEECCEECCCCC
5.2710551839
32C-linked_GlycosylationDHYAWTQWTSCSKTC
CCCEEECCEECCCCC
5.2710551839
38O-linked_GlycosylationQWTSCSKTCNSGTQS
CCEECCCCCCCCCCC
10.7122267737
41PhosphorylationSCSKTCNSGTQSRHR
ECCCCCCCCCCCHHE
45.4218452278
45PhosphorylationTCNSGTQSRHRQIVV
CCCCCCCCHHEEEEH
29.8618452278
90C-linked_GlycosylationLLGDFGPWSDCDPCI
EECCCCCHHHCHHHH
13.7410551839
90C-linked_GlycosylationLLGDFGPWSDCDPCI
EECCCCCHHHCHHHH
13.7410551839
130PhosphorylationAFQPCIPSKLCKIEE
EECCCCCHHHCCCCC
20.5324719451
162N-linked_GlycosylationKLECNGENDCGDNSD
EEEECCCCCCCCCCC
51.80-
162N-linked_GlycosylationKLECNGENDCGDNSD
EEEECCCCCCCCCCC
51.8017623646
278PhosphorylationFSSQGGSSFSVPIFY
CCCCCCCCCEEEEEE
25.4719007248
311PhosphorylationQASHKKDSSFIRIHK
HHHHCCCCCHHHHHH
35.7125003641
312PhosphorylationASHKKDSSFIRIHKV
HHHCCCCCHHHHHHH
34.5224719451
324N-linked_GlycosylationHKVMKVLNFTTKAKD
HHHHHHHCCCCCCHH
34.8917623646
324N-linked_GlycosylationHKVMKVLNFTTKAKD
HHHHHHHCCCCCCHH
34.8917623646
355PhosphorylationEYNSALYSRIFDDFG
CCCHHHHHHHCCCCC
21.5424719451
392O-linked_GlycosylationELKNSGLTEEEAKHC
HHHHCCCCHHHHHHH
44.8922267737
561PhosphorylationKQSPDYKSNAVDGQW
CCCCCCCCCCCCCCC
24.64-
568C-linked_GlycosylationSNAVDGQWGCWSSWS
CCCCCCCCCCCCCHH
14.9410551839
568C-linked_GlycosylationSNAVDGQWGCWSSWS
CCCCCCCCCCCCCHH
14.9410551839
571C-linked_GlycosylationVDGQWGCWSSWSTCD
CCCCCCCCCCHHCCC
7.4610551839
571C-linked_GlycosylationVDGQWGCWSSWSTCD
CCCCCCCCCCHHCCC
7.4610551839
574C-linked_GlycosylationQWGCWSSWSTCDATY
CCCCCCCHHCCCCCC
7.6710551839
574C-linked_GlycosylationQWGCWSSWSTCDATY
CCCCCCCHHCCCCCC
7.6710551839
727PhosphorylationRLYRIGESIELTCPK
HHHCCCCCEEEECCC
19.0224505115
731PhosphorylationIGESIELTCPKGFVV
CCCCEEEECCCCEEE
17.6124505115
742PhosphorylationGFVVAGPSRYTCQGN
CEEEECCCCEECCCC
36.68-
767PhosphorylationTCEKDTLTKLKGHCQ
EECCCHHHHHCCCCC
36.10-
855N-linked_GlycosylationERTRLSSNSTKKESC
HHHCCCCCCCCCHHC
50.7716335952
855N-linked_GlycosylationERTRLSSNSTKKESC
HHHCCCCCCCCCHHC
50.7716335952

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of CO6_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of CO6_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of CO6_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
CO5_HUMANC5physical
2808363
SART3_HUMANSART3physical
21988832
D19L3_HUMANDPY19L3physical
28514442
ACOT9_HUMANACOT9physical
28514442
B3GLT_HUMANB3GALTLphysical
28514442

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
612446Complement component 6 deficiency (C6D)
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of CO6_HUMAN

loading...

Related Literatures of Post-Translational Modification
C-linked Glycosylation
ReferencePubMed
"Structure of complement C6 suggests a mechanism for initiation andunidirectional, sequential assembly of membrane attack complex(MAC).";
Aleshin A.E., Schraufstatter I.U., Stec B., Bankston L.A.,Liddington R.C., DiScipio R.G.;
J. Biol. Chem. 287:10210-10222(2012).
Cited for: X-RAY CRYSTALLOGRAPHY (2.87 ANGSTROMS) OF 22-934, GLYCOSYLATION ATTRP-29; TRP-32; THR-38; ASN-324; THR-392; TRP-568 AND TRP-571,SUBUNIT, AND DISULFIDE BONDS.
"The four terminal components of the complement system are C-mannosylated on multiple tryptophan residues.";
Hofsteenge J., Blommers M., Hess D., Furmanek A., Miroshnichenko O.;
J. Biol. Chem. 274:32786-32794(1999).
Cited for: GLYCOSYLATION AT TRP-29; TRP-32; TRP-90; TRP-568; TRP-571 AND TRP-574.
N-linked Glycosylation
ReferencePubMed
"Structure of complement C6 suggests a mechanism for initiation andunidirectional, sequential assembly of membrane attack complex(MAC).";
Aleshin A.E., Schraufstatter I.U., Stec B., Bankston L.A.,Liddington R.C., DiScipio R.G.;
J. Biol. Chem. 287:10210-10222(2012).
Cited for: X-RAY CRYSTALLOGRAPHY (2.87 ANGSTROMS) OF 22-934, GLYCOSYLATION ATTRP-29; TRP-32; THR-38; ASN-324; THR-392; TRP-568 AND TRP-571,SUBUNIT, AND DISULFIDE BONDS.
"Human plasma N-glycoproteome analysis by immunoaffinity subtraction,hydrazide chemistry, and mass spectrometry.";
Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E.,Moore R.J., Smith R.D.;
J. Proteome Res. 4:2070-2080(2005).
Cited for: GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-324 AND ASN-855, AND MASSSPECTROMETRY.
Phosphorylation
ReferencePubMed
"Evaluation of the low-specificity protease elastase for large-scalephosphoproteome analysis.";
Wang B., Malik R., Nigg E.A., Korner R.;
Anal. Chem. 80:9526-9533(2008).
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-278, AND MASSSPECTROMETRY.

TOP